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ABSTRACT 
Leishmaniasis represents a spectrum of diseases caused by infection with protozoan pathogens of the genus Leishmania. It is 
a major neglected tropical disease associated with high rates of disability and death, with extended endemic areas in the 
Americas. Despite current therapeutic approaches, current treatments for leishmaniasis are unsatisfactory due to high 
associated toxicity, cost, complex administration and the emergence of resistant strains. Because of this, efforts have greatly 
increased over the last decade to identify novel compounds with anti-leishmanial properties. Thus, one strategy in the search 
for new compounds is the screening of molecules purified from plant sources. The current work reviewed the available 
information about the Argentinean natural sources reported as effective against Leishmania spp.; including: its relevant 
chemical compounds, efficiency and applied methodology. Reported studies need to be considered as precursors works to 
extend the search between the profuse native plants from Argentina. 
Keywords: Leishmaniasis, Natural compounds, Argentina, Complementary medicine 
INTRODUCTION 
Leishmaniasis represents a spectrum of diseases, highly 
associated to poverty, caused by infection with protozoan 
pathogens of the genus Leishmania, transmitted to a 
mammalian host via the bite of an infected female of sand 
flies [1]. It is a major neglected tropical disease associated 
with high rates of disability and death with an estimated 2 
million new cases annually [2]. Clinically, there are 3 
presentations of leishmaniasis: visceral, cutaneous and 
mucocutaneous. In the Americas, the endemic areas are 
extended from the South of United States to Argentina. In 
particular, the disease is endemic in 10 northern provinces of 
Argentina, and the incidence has been increasing annually 
since 1980 [3]. Although pentavalent antimonial drugs are 
the most prescribed treatment, several other interventions 
have been used with varying success. These include 
parenteral treatments with drugs such as pentamidine, 
amphotericin B, aminosidine and pentoxifylline, oral 
treatments with miltefosine and topical treatments with 
paromomycin (aminosidine) and aminoglycosides. Other 
treatments such as immunotherapy and thermotherapy have 
also been tested [4]. However, current treatments for 
leishmaniasis are unsatisfactory due to high associated 
toxicity, cost, complex administration and the emergence of 
resistant strains. Because of this, efforts have greatly 
increased over the last decade to identify novel compounds 
with anti-leishmanial properties [5-8]. Thus, one strategy in 
the search for new compounds is the screening of molecules 
purified from plant sources to be used alone or as a 
complement from the current available treatments. 
Recently, Bekhit et al. [9] reviewed many natural 
derivatives, including: flavonoids, chalcones, 
naphthoquinones, iridoids, saponins, quinolones, 
diterpenoids and lignans; with reported in vivo and in vitro 
activity; and scarce or null toxicity. No reports about 
secondary resistance to the mentioned compounds are 
available. However, as occurs between cancer 
chemotherapeutics agents, the existence of several 
acceptable treatment options increases the achievable 
alternatives in secondary resistant disease cases.  
Among the Argentinean natural sources, there are several 
native plants which evidenced activity against different 
Leishmania species. However, to promote the use of natural 
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derivatives, the scientific approaches to determine 
leishmanicidal properties needs to considerate some 
particularities. 
Plants conditions and origin 
In relation to the plant sources, it is known that bioactive 
compounds are the secondary metabolites defined by the 
plant physiology status [10]. Then, adaptive features to soils, 
temperature, light-dark cycles, water salinity and availability 
are very important determinants of secondary metabolites 
presence and concentration. For this reason, in the current 
review, we considered only studies which involved 
Argentinean native plants grown in the country. In fact, 
regardless of some properties reported in plants considered 
as native from Argentina; because they were obtained and 
harvested in other remote countries, these findings are out of 
consideration in the present work. 
EXPERIMENTAL APPROACHES TO DETERMINE 
LEISHMANICIDAL ACTIVITY  
Other opportune item to consider is related to the 
experimental methodology used to assign the leishmanicidal 
activity. Leishmania spp. is a digenetic organisms alternating 
between a flagellated promastigote, in the gut of the sand fly 
vector; and an intracellular amastigote, in the mammalian 
host. While, the in vitro systems may be potentially used for 
compounds which have direct lethal action on parasite; other 
compounds which actions are related to host defense system, 
cannot be study by this methodology. Therefore, sometimes, 
in vitro assays may not be transferable to in vivo situations 
[11]. 
In addition, inside of in vitro models, it is important to take 
into account the stages of development of the parasite used 
experimentally. The promastigotes grown in axenic cultures 
have been used to screen potential anti-leishmanial agents 
and the advantages of this system explain its wide 
popularity. The simplest model to be utilized is the one in 
which the promastigotes multiply in cell free media [12]. 
The technique is simple and easily applicable; however, the 
metabolism and ecology of promastigote differ widely from 
those of amastigote (target form). In consequence, the 
screening data obtained from in vitro test with promastigote 
have very little value in animals [13]. Ideally, to be efficient 
and exhaustive, a drug screening procedure requires 
conditions that mimic the environment encountered by the 
target cell. For Leishmania, intracellular form of the parasite 
(amastigotes) might represent the typical conditions. In fact, 
a direct comparison of the drug susceptibility towards 
standard anti-leishmanial drugs, between amastigotes and 
axenic amastigotes, demonstrates a good correlation to 
many, if not all the drug tested [14]. 
About the in vivo models related to leishmaniasis, when 
cutaneous forms are studied, the methods to infect animals 
are intradermal or subcutaneous inoculations [15,16]; while 
in the visceral forms: intravenous, intraperitoneal and 
intracardiac inoculations are commonly used [17,18]. The 
assays outputs can change between lesions measurements, 
pathological analysis and serological determinations. 
Usually, blood samples and dissected organs are used to 
perform DNA, proteins, cytokines or inflammatory cells 
determinations.   
A less common method is the use of bioluminescent 
parasites to quantify Leishmania spp. infection in the ear; 
which is a more sophisticated and accurate approach 
compared with the more traditional measurements of lesion 
diameter, volume, and thickness [19]. 
Actually, the vast majority of leishmaniasis in vivo models 
use a needle challenge of parasites alone and in large 
quantities. Moreover, Leishmania spp. is transmitted to 
animals and humans by a sand fly vector. The current use of 
murine models has been questioned in that it does not 
represent the clinical disease progression or immune 
response seen in humans [20].  
Argentinean plants effective against Leishmania spp. 
In Table 1 are summarized the reported Argentinean plants 
bioactive against Leishmania spp. To be exhaustive, the 
parasites species and stages, plant sources used and main 
chemical groups described in the bibliography, are ordered 
and enumerated. 
At least, 8 different species were reported as leishmanicidal 
agents, included into 5 taxonomic families. All the 
mentioned plants were reported as used by its 
ethnopharmacological properties, and none of them were 
originally related to the leishmaniasis disease. 
From a chemical point of view, there are 2 different species 
without an analytical characterization of metabolites. Both, 
the methanolic extracts of Mikania periplocifolia and 
Parietaria debilis evidenced leishmanicidal activity against 
L. mexicana amastigotes, but not chemical structures were
described as related to the induced cytotoxicity. By other
side, phenols, and particularly flavonoids, are the most
common plant metabolites related to the anti-parasitic
activity. The 3-Heptadecyl-5-methoxy-phenol and 1,3-
Dimethoxy-5-pentadecyl-benzene derived from Oxalis
erythrorhiza; 2,8-dihydroxy-7H-furo[2,3-f]chromen-7-one
derived from Tibouchina paratropica; hispidulin from
Ambrosia tenuifolia; santin from Eupatorium buniifolium; 5-
desmethylsinensetin and eupatorin obtained from Stevia
satureiifolia represent the major group of identified
compounds related to the Argentinean anti-leishmanial
natural derived compounds. One particular consideration is
necessary to embelin, a natural derivative identified from
Oxalis erythrorhiza. The compound is widely reported as
component of herbs used in the traditional medicine of India.
Between its described properties, it is relevant to mention
the effects on chronic diseases such as tumors, autoimmune
inflammatory diseases, parasitic infections, microbial
infections, diabetes, obesity and cardio-cerebral vascular
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diseases [27]. Finally, lindbergin E, F, G and H isolated 
from Elaphoglossum lindbergii are the unique 
acylphloroglucinos which reported cytotoxicity in 
Leishmania species. 
Table 1. Native plants form Argentina reported as effective against Leishmania spp. 
Plant ID Plant source Chemical group Leishmania spp. Assayed system References 
Oxalis erythrorhiza 
(Oxalidaceae) 
















Aerial parts None L. mexicana Amastigotes, in vitro [23] 
Parietaria debilis 
(Urticaceae) 












Promastigotes, in vitro [25] 
Stevia satureiifolia 
(Asteraceae) 
Aerial parts Flavonoids L. braziliensis Promastigotes, in vitro [26] 
CONCLUSION 
The reviewed works provide a several number of promissory 
compounds; however, to confirm its reported activities, the 
uses of in vivo models result mandatory. Notwithstanding, in 
most of the cases, the chemical characterization of bioactive 
molecules could facilitate further researches and promote 
synthetic molecules production and semi-synthetic 
modifications destined to enhance the original properties 
described and its bioavailabitlity. Finally, well conduced 
researches between Argentinean natural sources are 
promissory to detect plant derivatives with therapeutic 
properties against leishmaniasis. 
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